SMARCA2 drugs for Non-Small Cell Lung Cancer

2 tracked SMARCA2 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the SMARCA2 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

1 Phase 21 preclinical / unstaged

Head-to-head evidence: PLX-61639 vs PRT3789

The roster

← all SMARCA2 drugs